1,721,011 research outputs found
Supplemental Material - Albumin versus balanced crystalloid for resuscitation in the treatment of sepsis: A protocol for a randomised controlled feasibility study, “ABC-Sepsis”
No full textSupplemental Material for Albumin versus balanced crystalloid for resuscitation in the treatment of sepsis: A protocol for a randomised controlled feasibility study, “ABC-Sepsis” by John Cafferkey, Andrew Ferguson, Julia Grahamslaw, Katherine Oatey, John Norrie, Timothy Walsh, Nazir Lone, Daniel Horner, Andy Appelboam, Peter Hall, Richard Skipworth, Derek Bell, Kevin Rooney, Manu Shankar-Hari, Alasdair Corfield and Alasdair Gray in Journal of the Intensive Care Society</p
Covid-ImmunoPhenotyping - a preliminary data release, May 22. 2020
No full textDescribes the study, its methodology and presents the preliminary findings. A number of biomarkers of COVID-19 severity are emerging
Additional file 2: of Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study
No full textTable S1. Characteristics of patients with sepsis included in the study. Results are shown for all patients and for survivors and non-survivors (DOCX 14Â kb
Going Beyond Counting First Authors in Author Co-citation Analysis
Full text linkThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
Additional file 11: of Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study
No full textFigure S6. Comparison by nosocomial infection status. Comparison of expression of PD-1, PD-L1 and PD-L2 between patients who developed a nosocomial infection and those who did not. (DOCX 253Â kb
Additional file 12: of Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study
No full textFigure S7. PD-L1 comparison by nosocomial infection status in patients with ICU length of stay ≥7 days. PD-L1 expression by lymphocytes was compared between patients who developed a nosocomial infection and those who did not, when patients with an ICU length of stay <7 days were excluded. (DOCX 24 kb
Additional file 13: of Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study
No full textFigure S8. Comparison by nosocomial infection status in patients with ICU length of stay ≥7 days. Comparison of PD-1, PD-L1 and PD-L2 expression by B and CD4+ T cells between patients who developed a nosocomial infection and those who did not, when patients with an ICU length of stay <7 days were excluded. (DOCX 237 kb
Additional file 6: of Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study
No full textFigure S2. B cell subset MFI. Comparison of expression of PD-1, PD-L1 and PD-L2 as determined by MFI on B cell subsets (CD27+ and CD27-) in patients with sepsis and healthy controls. (DOCX 251Â kb
Additional file 16: of Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study
No full textFigure S11. Serum versus cell surface expression. Serum levels of PD-1 and PD-L1 are plotted against cell surface expression levels on B cells and CD4+ T cells. (DOCX 286Â kb
- …
